Fulgent Genetics, Inc.
NASDAQ:FLGT
19.43 (USD) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2001 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||
| Net Income
| -167.825 | 141.923 | 506.239 | 214.31 | -0.411 | -5.607 | -2.51 | -5.388 | -4.985 | -0.99 | 507.364 |
| Depreciation & Amortization
| 31.757 | 32.662 | 11.004 | 2.962 | 2.107 | 2.163 | 1.728 | 1.17 | 0.575 | 0.196 | 11.004 |
| Deferred Income Tax
| 11.466 | 0.831 | -7.84 | -1.398 | -0.021 | 0.036 | -0.336 | 0.246 | -3.329 | 0 | 0 |
| Stock Based Compensation
| 42.922 | 32.64 | 15.882 | 8.157 | 3.209 | 2.304 | 2.119 | 4.654 | 8.156 | 0 | 15.882 |
| Change In Working Capital
| 2.841 | 2.005 | -2.676 | -91.451 | -0.915 | -1.244 | -0.714 | -1.857 | -1.748 | -0.323 | 0 |
| Accounts Receivables
| 2.388 | 68.638 | 42.3 | -178.48 | -0.839 | -1.97 | 0.214 | -2.322 | -1.779 | -0.416 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | -36.181 | -30.492 | -23.451 | -2.345 | -0.331 | 0 |
| Accounts Payables
| -6.896 | -25.339 | -12.206 | 22.617 | -0.329 | 0.102 | -0.363 | 1.094 | 0.132 | 0.15 | 0 |
| Other Working Capital
| 7.349 | -41.294 | -32.77 | 64.412 | 0.253 | 36.805 | 29.927 | 22.822 | 2.244 | 0.274 | 0 |
| Other Non Cash Items
| 105.842 | 43.459 | 15.968 | 8.048 | 1.548 | 1.673 | 1.044 | 5.58 | 0.362 | -3.28 | -534.25 |
| Operating Cash Flow
| 27.003 | 253.52 | 538.577 | 140.628 | 5.517 | -0.675 | 1.331 | 4.405 | -0.969 | -4.397 | 534.25 |
| Investing Activities: | |||||||||||
| Investments In Property Plant And Equipment
| -22.207 | -18.775 | -23.844 | -36.51 | -1.319 | -2.832 | -5.356 | -3.788 | -2.1 | -0.731 | 0 |
| Acquisitions Net
| 0.376 | -182.679 | -61.868 | -2.591 | 0.137 | 0.51 | 2.461 | 0.01 | 3.57 | 0 | 0 |
| Purchases Of Investments
| -491.914 | -432.982 | -730.49 | -324.359 | -52.077 | -24.187 | -11.659 | -39.017 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 552.643 | 372.71 | 269.591 | 37.014 | 24.35 | 27.969 | 14.966 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 61.504 | 0.412 | 0.063 | 0.008 | -0.137 | -0.51 | -2.461 | 0.01 | -0.105 | -0.049 | 0 |
| Investing Cash Flow
| 38.898 | -261.314 | -546.548 | -326.438 | -29.046 | 0.95 | -2.049 | -42.795 | -2.205 | -0.78 | 0 |
| Financing Activities: | |||||||||||
| Debt Repayment
| -4.996 | -1.067 | -0.011 | -15.019 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 0.003 | 0.031 | 89.561 | 246.19 | 28.758 | 0.015 | -0.77 | 63.77 | 0 | 0 | 0 |
| Common Stock Repurchased
| -27.792 | -74.337 | -4.155 | -0.062 | -0.021 | 0 | 0 | -6.587 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | -4.592 | 0 | 0 | 0 |
| Other Financing Activities
| -14.997 | -1.768 | -4.145 | 45.161 | 0.038 | 0.015 | -0.77 | 56.968 | 3.5 | 4 | 0 |
| Financing Cash Flow
| -47.785 | -77.141 | 85.395 | 261.251 | 28.775 | 0.015 | -0.77 | 45.789 | 3.5 | 4 | 0 |
| Other Information: | |||||||||||
| Effect Of Forex Changes On Cash
| -0.149 | -0.453 | 0.034 | 0.02 | -0.017 | -0.044 | 0.081 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| 17.967 | -85.388 | 77.468 | 75.461 | 5.229 | 0.246 | -1.407 | 7.399 | 0.326 | -1.177 | 534.25 |
| Cash At End Of Period
| 97.473 | 79.506 | 164.894 | 87.426 | 11.965 | 6.736 | 6.49 | 7.897 | 0.498 | 0.172 | 534.25 |